$Ironwood Pharmaceuticals (IRWD.US)$ shares sank almost 40% after the drugmaker said its global phase III trial of Apraglutide, a treatment for short bowel syndrome, missed two of its four secondary goals.
That muddies the prospects for the company that's seeking to expand its product pipeline beyond Linzess.
Ironwood, which has been operating at a loss, sourced almost ll of its $117.6 million revenue in 2023 from its collaborati...

$Cassava Sciences (SAVA.US)$With the rate of CTB on shorting on SAVA, Shorts greed have officially exposed them on the illegal shorting with no real shares left to borrow to short . They've now been tracked and evidence against them for more financial harm than they caused!

$Cassava Sciences (SAVA.US)$ 2 Phase 3 trials with less than 10 months left on one of them, with promising results from the previous trials and yet the Market Manipulators have brought the stock down and shorted it for the last 3 years, almost 6% today to be in $22 price range with the SEC and DOJ doing nothing to stop the manipulation. Meanwhile, INSTITUTIONAL HOLDING seems to be now at an all time high. These share prices are not real as you can see by the continued growth of institutions!

$Iovance Biotherapeutics (IOVA.US)$ Opps… just longed yesterday😭 Should wait for today’s bargain.

$Advanced Micro Devices (AMD.US)$ Why going down?

$Cosmos Health (COSM.US)$ dead no movement